You are here

  • Home
  • Archive
  • Volume 5, Issue 4
  • Review: newer technologies improve sensitivity in detecting uterine cervical lesions but at a substantially increased cost

Article Text

Article menu
Download PDFPDF
Diagnosis
Review: newer technologies improve sensitivity in detecting uterine cervical lesions but at a substantially increased cost

https://doi.org/10.1136/ebm.5.4.124

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    . McCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Rockville, MD: Agency for Health Care Policy and Research; February 1999. AHCPR publication no. 99-E010. http://www.ahcpr.gov/clinic/cervsum.htm..

    
 
 QUESTION: In adult women at average risk for cervical cancer, what is the accuracy of the conventional Papanicolaou (Pap) test and of new technologies (thin layer cytology, computer rescreening, and algorithm based decision making) in detecting cervical cancer and cervical intraepithelial neoplasia?

    Data sources

    Studies were identified by searching Medline, CancerLIT, HealthSTAR, CINAHL, EMBASE/Excerpta Medica, and EconLIT; scanning recent issues of selected journals; and contacting manufacturers of automated cytologic devices and relevant professional societies.

    Study selection

    Studies were selected if cervical cytology was evaluated as a screening test, the reference standard was histology or colposcopy, and sensitivity and specificity (or relative true positive and false positive rates) could be calculated. Cytology was an acceptable reference standard if the studies also included an independent panel of cytology specialists to arrive at a consensus diagnosis and a 2 arm prospective study design was used. The …

    View Full Text

    Footnotes

    • Source of funding: Agency for Health Care Policy and Research.

    • For correspondence: Director, Center for Practice and Technology Assessment, Agency for Health Care Policy and Research, 6010 Executive Boulevard, Suite 300, Rockville, MD 20852, USA. Fax +1 919 286 5601.